Evidence map›Paper›PMID 32050709›Full record

ArticleVaccines2020

Emergency Foot-and-Mouth Disease Vaccines A Malaysia 97 and A

Nagendrakumar B, Aldo Dekker, Phaedra L Eblé, Froukje van Hemert-Kluitenberg, Klaas Weerdmeester, Jacquelyn Horsington, Wilna Vosloo W

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Nagendrakumar BAustralian Animal Health Laboratory, CSIRO-Health & Biosecurity, Geelong 3220, Australia.
Aldo DekkerWageningen Bioveterinary Research (WBVR), Department of Virology, Laboratory Vesicular Diseases, Houtribweg 39, 8221 RA Lelystad, The Netherlands.
Phaedra L EbléWageningen Bioveterinary Research (WBVR), Department of Virology, Laboratory Vesicular Diseases, Houtribweg 39, 8221 RA Lelystad, The Netherlands.
Froukje van Hemert-KluitenbergWageningen Bioveterinary Research (WBVR), Department of Virology, Laboratory Vesicular Diseases, Houtribweg 39, 8221 RA Lelystad, The Netherlands.
Klaas WeerdmeesterWageningen Bioveterinary Research (WBVR), Department of Virology, Laboratory Vesicular Diseases, Houtribweg 39, 8221 RA Lelystad, The Netherlands.
Jacquelyn HorsingtonAustralian Animal Health Laboratory, CSIRO-Health & Biosecurity, Geelong 3220, Australia.
Wilna Vosloo WAustralian Animal Health Laboratory, CSIRO-Health & Biosecurity, Geelong 3220, Australia.
Wageningen University & Research · NLCommonwealth Scientific and Industrial Research Organisation · AU

Funding

Meat and Livestock Australia FMD Risk Management Project P.PSH 0558 and P.PSH.0652
6 · The paper itself

Abstract

The continuous emergence of foot-and-mouth disease virus (FMDV) serotype A variants in South East Asia is of concern for international FMDV antigen banks, especially when in vitro tests predict a low antigenic match. A vaccination-challenge study was performed by using two emergency FMDV vaccines with A

Indexed as

cross-protectionFMDfoot-and-mouth disease virusheterologous protectionvaccinevaccine efficacy

Identifiers

PMID32050709
PMCPMC7157217
OpenAlexW3005003181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.